BMRN - Company ID 0001048477
The table below shows BIOMARIN PHARMACEUTICAL INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.22B | $1.25B | $1.21B | $1.05B | $675.45M | $972.15M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $903.91M | $790.27M | $855.86M | $739.18M | $777.55M | $691.23M |
| Inventory | $1.27B | $1.38B | $1.34B | $1.27B | $1.18B | $1.18B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $4.61B |
| $3.85B |
| $3.81B |
| $3.47B |
| $3.06B |
| $3.26B |
| Property, plant & equipment | $958.07M | $1.04B | $1.03B | $1.03B | $1.05B | $1.05B |
| Goodwill | $196.20M | $196.20M | $196.20M | $196.20M | $196.20M | $196.20M |
| Total assets | $8.59B | $7.61B | $7.46B | $7.15B | $6.85B | $7.07B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $793.15M | $798.44M | $684.25M | $628.21M | $715.66M | $1.07B |
| Long-term debt | $1.43B | - | - | - | - | - |
| Total liabilities | $2.38B | $1.56B | $1.43B | $1.35B | $1.44B | $1.78B |
| Retained earnings | $259.73M | $200.78M | $231.52M | -$9.01M | -$319.64M | -$425.72M |
| Total equity | $6.21B | $6.06B | $6.03B | $5.79B | $5.41B | $5.29B |